Charles W. Newhall III, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 25,000 shares at $51.55 ($1.3M) on 2025-10-09, disclosed to the SEC on 2025-10-10.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.73 | 23,800 | $1.2M | 95.1% |
| 2 | $51.55 | 1,200 | $62K | 4.9% |
| Total | $50.77 avg | 25,000 | $1.3M | 100% |
| Filing → |
| SUPN | SELL | 2025-08-26 | $64K | — | Filing → |
| SUPN | SELL | 2024-11-12 | $388K | — | Filing → |
| SUPN | SELL | 2023-11-20 | $70K | — | Filing → |